Saiki A - Search Results

1

Predictive Value of the Cardio-Ankle Vascular Index for Cardiovascular Events in Patients at Cardiovascular Risk.

Miyoshi T, Ito H, Shirai K, Horinaka S, Higaki J, Yamamura S, Saiki A, Takahashi M, Masaki M, Okura T, Kotani K, Kubozono T, Yoshioka R, Kihara H, Hasegawa K, Satoh-Asahara N, Orimo H; CAVI‐J (Prospective Multicenter Study to Evaluate Usefulness of Cardio‐Ankle Vascular Index in Japan) investigators *. Miyoshi T, et al. Among authors: saiki a. J Am Heart Assoc. 2021 Aug 17;10(16):e020103. doi: 10.1161/JAHA.120.020103. Epub 2021 Aug 7. J Am Heart Assoc. 2021. PMID: 34369198 Free PMC article.

2

Reduction of visceral adiposity after operation in a subject with insulinoma.

Saiki A, Miyashita Y, Wakabayashi M, Kameda N, Shirai K. Saiki A, et al. J Atheroscler Thromb. 2004;11(4):209-14. doi: 10.5551/jat.11.209. J Atheroscler Thromb. 2004. PMID: 15356380 Free article.

3

Pitavastatin enhanced lipoprotein lipase expression in 3T3-L1 preadipocytes.

Saiki A, Murano T, Watanabe F, Oyama T, Miyashita Y, Shirai K. Saiki A, et al. J Atheroscler Thromb. 2005;12(3):163-8. doi: 10.5551/jat.12.163. J Atheroscler Thromb. 2005. PMID: 16020917 Free article.

4

The angiotensin II receptor antagonist valsartan enhances lipoprotein lipase mass in preheparin serum in type 2 diabetes with hypertension.

Saiki A, Ohira M, Endo K, Koide N, Oyama T, Murano T, Miyashita Y, Shirai K. Saiki A, et al. Diabetes Res Clin Pract. 2006 Dec;74(3):242-8. doi: 10.1016/j.diabres.2006.04.004. Epub 2006 May 19. Diabetes Res Clin Pract. 2006. PMID: 16713009 Clinical Trial.

5

Preheparin serum lipoprotein lipase mass might be a biomarker of metabolic syndrome.

Saiki A, Oyama T, Endo K, Ebisuno M, Ohira M, Koide N, Murano T, Miyashita Y, Shirai K. Saiki A, et al. Diabetes Res Clin Pract. 2007 Apr;76(1):93-101. doi: 10.1016/j.diabres.2006.08.004. Epub 2006 Sep 7. Diabetes Res Clin Pract. 2007. PMID: 16956692

6

Effect of metformin on serum lipoprotein lipase mass levels and LDL particle size in type 2 diabetes mellitus patients.

Ohira M, Miyashita Y, Ebisuno M, Saiki A, Endo K, Koide N, Oyama T, Murano T, Watanabe H, Shirai K. Ohira M, et al. Among authors: saiki a. Diabetes Res Clin Pract. 2007 Oct;78(1):34-41. doi: 10.1016/j.diabres.2007.02.012. Epub 2007 Mar 19. Diabetes Res Clin Pract. 2007. PMID: 17374417 Clinical Trial.

7

[Practical method of formula diet for metabolic syndrome].

Saiki A, Shirai K. Saiki A, et al. Nihon Rinsho. 2006 Dec 28;64 Suppl 9:569-73. Nihon Rinsho. 2006. PMID: 17458283 Review. Japanese. No abstract available.

8

[Hypolipidemia in malabsorption syndrome].

Saiki A, Suzuki Y, Shirai K. Saiki A, et al. Nihon Rinsho. 2007 Jul 28;65 Suppl 7:621-6. Nihon Rinsho. 2007. PMID: 17824099 Review. Japanese. No abstract available.

9

Suppression of lipoprotein lipase expression in 3T3-L1 cells by inhibition of adipogenic differentiation through activation of the renin-angiotensin system.

Saiki A, Koide N, Watanabe F, Murano T, Miyashita Y, Shirai K. Saiki A, et al. Metabolism. 2008 Aug;57(8):1093-100. doi: 10.1016/j.metabol.2008.03.014. Metabolism. 2008. PMID: 18640387

10

Protective effects of efonidipine, a T- and L-type calcium channel blocker, on renal function and arterial stiffness in type 2 diabetic patients with hypertension and nephropathy.

Sasaki H, Saiki A, Endo K, Ban N, Yamaguchi T, Kawana H, Nagayama D, Ohhira M, Oyama T, Miyashita Y, Shirai K. Sasaki H, et al. Among authors: saiki a. J Atheroscler Thromb. 2009 Oct;16(5):568-75. doi: 10.5551/jat.1628. Epub 2009 Sep 14. J Atheroscler Thromb. 2009. PMID: 19749494 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

187 results

Search Page